comparemela.com

Latest Breaking News On - Better therapeutics daily - Page 1 : comparemela.com

MMCAP International Inc SPC Has $65,000 Stock Holdings in Better Therapeutics, Inc (NASDAQ:BTTX)

MMCAP International Inc. SPC trimmed its position in Better Therapeutics, Inc. (NASDAQ:BTTX – Free Report) by 77.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 356,270 shares of the company’s stock after selling 1,226,809 shares during the period. MMCAP International Inc. SPC’s […]

Better Therapeutics, Inc (NASDAQ:BTTX) Sees Significant Decrease in Short Interest

Better Therapeutics, Inc. (NASDAQ:BTTX – Get Free Report) saw a significant drop in short interest during the month of January. As of January 31st, there was short interest totalling 960,700 shares, a drop of 29.9% from the January 15th total of 1,370,000 shares. Based on an average daily trading volume, of 1,840,000 shares, the days-to-cover […]

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Update

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Update
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Up 20 2% in January

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Up 20 2% in January
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Up 20 2% in January

Better Therapeutics, Inc (NASDAQ:BTTX) Short Interest Up 20 2% in January
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.